MERCI: a machine learning approach to identifying hydroxychloroquine retinopathy using mfERG

[1] Cairoli E(2012)Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect Lupus 21 1178-1182

[2] Rebella M(2016)Association of triple therapy with improvement in cholesterol profiles over two-year followup in the treatment of early aggressive rheumatoid arthritis trial Arthritis Rheumatol 68 577-586

[3] Danese N(1996)Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis Lupus 5 S16-S22

[4] Charles-Schoeman C(2010)Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus J Rheumatol 37 1136-1142

[5] Wang X(2010)Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review Ann Rheum Dis 69 20-28

[6] Lee YY(2011)The role of antimalarial agents in the treatment of SLE and lupus nephritis Nat Rev Nephrol 7 718-729

[7] Petri M(2013)Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus a case-control study JAMA Dermatol 149 935-940

[8] Penn SK(2015)Chloroquine and hydroxychloroquine increase retinal pigment epithelial layer permeability J Biochem Mol Toxicol 29 299-304

[9] Kao AH(2014)The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy JAMA Ophthalmol 132 1453-1460

[10] Schott LL(2007)Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography Am J Ophthalmol 143 801-809

[1] Cairoli E(2012)Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect Lupus 21 1178-1182

[2] Rebella M(2016)Association of triple therapy with improvement in cholesterol profiles over two-year followup in the treatment of early aggressive rheumatoid arthritis trial Arthritis Rheumatol 68 577-586

[3] Danese N(1996)Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis Lupus 5 S16-S22

[4] Charles-Schoeman C(2010)Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus J Rheumatol 37 1136-1142

[5] Wang X(2010)Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review Ann Rheum Dis 69 20-28

[6] Lee YY(2011)The role of antimalarial agents in the treatment of SLE and lupus nephritis Nat Rev Nephrol 7 718-729

[7] Petri M(2013)Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus a case-control study JAMA Dermatol 149 935-940

[8] Penn SK(2015)Chloroquine and hydroxychloroquine increase retinal pigment epithelial layer permeability J Biochem Mol Toxicol 29 299-304

[9] Kao AH(2014)The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy JAMA Ophthalmol 132 1453-1460

[10] Schott LL(2007)Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography Am J Ophthalmol 143 801-809